NCT00543504 2020-06-30Bevacizumab in Multiple Phase I CombinationsM.D. Anderson Cancer CenterPhase 1 Completed343 enrolled
NCT01287546 2017-02-15A Study of LY2875358 in Participants With Advanced CancerEli Lilly and CompanyPhase 1 Completed117 enrolled
NCT00895128 2015-07-13Study of Erlotinib in Combination With DasatinibM.D. Anderson Cancer CenterPhase 1 Completed65 enrolled